Skip to main content

Pizzie Nick's Form 4 filing

Axsome Therapeutics, Inc. (AXSM) · filed Feb 14, 2025

Accession no.
0000950170-25-021716
Filed
Feb 14, 2025
Trade date
Feb 13-14, 2025
Filing delay
1 day
Rule 10b5-1 plan
Checked

This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.95M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Pizzie NickCIK 0001742143Officer (Chief Financial Officer)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 13, 2025Common StockMOption exerciseAcquired+12,000$3.50+$42,00054,187Direct
Feb 13, 2025Common StockSSaleDisposed−12,000$129.86−$1,558,32042,187Direct
Feb 14, 2025Common StockMOption exerciseAcquired+3,000$3.50+$10,50045,187Direct
Feb 14, 2025Common StockSSaleDisposed−3,000$131.07−$393,21042,187Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Feb 13, 2025Common StockMOption exerciseDisposed−12,000$3.50−$42,0000Direct
Feb 14, 2025Common StockMOption exerciseDisposed−3,000$3.50−$10,5000Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)